MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41591-019-0400-z

Медицинская библиотека · Nature medicine · 2019

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.

Toffalori Cristina, Zito Laura, Gambacorta Valentina, Riba Michela, Oliveira Giacomo, Bucci Gabriele, Barcella Matteo, Spinelli Orietta, Greco Raffaella, Crucitti Lara, Cieri Nicoletta, Noviello Maddalena, Manfredi Francesco, Montaldo Elisa, Ostuni Renato, Naldini Matteo M, Gentner Bernhard, Waterhouse Miguel, Zeiser Robert, Finke Jurgen, Hanoun Maher, Beelen Dietrich W, Gojo Ivana, Luznik Leo, Onozawa Masahiro, Teshima Takanori, Devillier Raynier, Blaise Didier, Halkes Constantijn J M, Griffioen Marieke, Carrabba Matteo G, Bernardi Massimo, Peccatori Jacopo, Barlassina Cristina, Stupka Elia, Lazarevic Dejan, Tonon Giovanni, Rambaldi Alessandro, Cittaro Davide, Bonini Chiara, Fleischhauer Katharina, Ciceri Fabio, Vago Luca

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Transplantation of hematopoietic cells from a healthy individual (allogeneic hematopoietic cell transplantation (allo-HCT)) demonstrates that adoptive immunotherapy can cure blood cancers: still, post-transplantation relapses remain frequent. To explain their drivers, we analyzed the genomic and gene expression profiles of acute myeloid leukemia (AML) blasts purified from patients at serial time-points during their disease history. We identified a transcriptional signature specific for post-transplantation relapses and highly enriched in immune-related processes, including T cell costimulation and antigen presentation. In two independent patient cohorts we confirmed the deregulation of multiple costimulatory ligands on AML blasts at post-transplantation relapse (PD-L1, B7-H3, CD80, PVRL2), mirrored by concomitant changes in circulating donor T cells. Likewise, we documented the frequent loss of surface expression of HLA-DR, -DQ and -DP on leukemia cells, due to downregulation of the HLA class II regulator CIITA. We show that loss of HLA class II expression and upregulation of inhibitory checkpoint molecules represent alternative modalities to abolish AML recognition from donor-derived T cells, and can be counteracted by interferon-γ or checkpoint blockade, respectively. Our results demonstrate that the deregulation of pathways involved in T cell-mediated allorecognition is a distinctive feature and driver of AML relapses after allo-HCT, which can be rapidly translated into personalized therapies.

Для цитирования: Toffalori Cristina, Zito Laura, Gambacorta Valentina, Riba Michela, Oliveira Giacomo, Bucci Gabriele, Barcella Matteo, Spinelli Orietta, Greco Raffaella, Crucitti Lara, Cieri Nicoletta, Noviello Maddalena, Manfredi Francesco, Montaldo Elisa, Ostuni Renato, Naldini Matteo M, Gentner Bernhard, Waterhouse Miguel, Zeiser Robert, Finke Jurgen, Hanoun Maher, Beelen Dietrich W, Gojo Ivana, Luznik Leo, Onozawa Masahiro, Teshima Takanori, Devillier Raynier, Blaise Didier, Halkes Constantijn J M, Griffioen Marieke, Carrabba Matteo G, Bernardi Massimo, Peccatori Jacopo, Barlassina Cristina, Stupka Elia, Lazarevic Dejan, Tonon Giovanni, Rambaldi Alessandro, Cittaro Davide, Bonini Chiara, Fleischhauer Katharina, Ciceri Fabio, Vago Luca. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.. Nature medicine. 2019. DOI: 10.1038/s41591-019-0400-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.